Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visudyne PDT for Vertebral Metastases
NCT02464761Phase 1Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jun 2011
- Primary completion
- Sep 2017
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of verteporfin in vertebral metastases, sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Intraoperative dosimetry. Started Jun 2011; status: completed.
02
Drugs
verteporfin
03
Conditions
vertebral metastases
Beyond the preview
Go deeper on NCT02464761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02464761.